Tirzepatide is a relatively new medication, but it has been studied extensively in clinical trials. Overall, it appears to be a safe and effective medication for the treatment of type 2 diabetes and obesity.
The most common side effects of Tirzepatide are gastrointestinal (GI) in nature, such as nausea, vomiting, diarrhea, and constipation. These side effects are typically mild to moderate and occur more often when starting treatment or increasing the dose. Most GI side effects resolve on their own within a few weeks or months.
Other potential side effects of Tirzepatide include:
- Low blood sugar (hypoglycemia)
- Allergic reactions
- Pancreatitis
- Gallbladder problems
- Increased thyroid hormone levels (hyperthyroidism)
- Depression
Tirzepatide is not recommended for people with a history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or pancreatitis. It is also not recommended for people who are pregnant or breastfeeding.
Overall, Tirzepatide is a safe and effective medication for the treatment of type 2 diabetes and obesity. However, it is important to be aware of the potential side effects and to talk to your medical provider about whether Tirzepatide is right for you.